COVID-19 Vaccine Trial Paused, Due To Illness In One Volunteer
A large study of a COVID-19 vaccine candidate has been put on hold after one of the volunteers became ill.
Pharmaceuticals
U.S. Reaches $2.1 Billion Deal With Sanofi, GlaxoSmithKline For COVID-19 Vaccine Push
This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.
FDA Withdraws Emergency Use Authorization For Hydroxychloroquine
Emergency use authorization makes it easier for doctors to use a drug in a manner not specifically approved by the Food and Drug Administration. The FDA granted these drugs this status in March.
Amid High Stakes, China Is Fast-Tracking COVID-19 Vaccine Efforts
Experts say the Communist Party sees more at stake than public health. One of the biggest concerns is the economy. China is also looking to defuse criticism over its early handling of the outbreak.
French Drug Giant Sanofi Takes Heat After Suggesting U.S. May Get 1st Vaccine Access
An uproar followed comments by Sanofi's CEO that if the company develops a vaccine, doses would likely go to Americans first. The board president later insisted, "Any vaccine will be a public good."
Remdesivir Distribution Causes Confusion, Leaves Some Hospitals Empty-Handed
Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.
Putting A Price On COVID-19 Treatment Remdesivir
Gilead Sciences has committed to donating the initial supply of the experimental antiviral drug. But executives said the company will need to make expanded production of the treatment sustainable.
Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.
What Would It Take To Bring More Pharmaceutical Manufacturing Back To The U.S.?
Experts say it could be dangerous to rely on overseas production of medicine in a crisis, but the U.S. largely does. Rebuilding domestic capacity would take years and substantial investments.
Coronavirus Vaccine? Two Pharmaceutical Giants Collaborating To Develop One
Pharmaceutical companies GSK and Sanofi are partnering to work on several vaccine candidates to fight the coronavirus.